Peer-influenced content. Sources you trust. No registration required. This is HCN.

Oncology News Central (ONC)“It’s Dire”: Unprecedented Oncologist Faculty Departures Prompt ASCO Response

ONC

This article discusses ASCO’s response to the concerning exodus of oncologists from academic institutions, with eight new recommendations aimed at addressing workforce retention issues. The guidance targets specific pain points including role delineation, time allocation, research support, and equitable paths for advancement to help stem the loss of faculty, particularly junior oncologists, to industry and other settings.


⚕️Key Clinical Considerations⚕️

  • The departure of oncologists from academic centers is described as “dire,” particularly among junior faculty, threatening the clinical research pipeline and future cancer treatment innovations.
  • ASCO’s recommendations include better-defined roles (clinicians, investigators, educators), specific time allocation metrics, protected research time, and equitable promotion pathways.
  • Success measures for these recommendations include increased clinical investigator recruitment/retention and more robust clinical research protocol enrollment.
  • Implementation challenges exist as ASCO lacks enforcement power, though recommendations may become competitive advantages for institutions seeking to recruit and retain talent.
  • Academic leaders note these guidelines serve as conversation starters, potentially leading to transparent metrics showing which institutions truly prioritize research and education missions.

🎯 Clinical Practice Impact 🎯

  • Patient Communication: Potential limitation of clinical trial availability and innovative treatment options if academic oncologist shortages continue, requiring transparent discussions with patients.
  • Practice Integration: Department chairs should evaluate faculty workloads against ASCO’s recommended role delineation and time allocation percentages, identifying major gaps.
  • Risk Management: Academic centers face increased competitive disadvantages without addressing retention issues, potentially losing qualified oncologists to better-balanced opportunities in industry.
  • Action Items: Leaders should prioritize protected research time, establish clear metrics for promotion across all faculty roles, and transparently communicate expected time commitments to faculty.

More on Healthcare Workforce

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form